Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

NCT00663936 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

373

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: T-817MA
DRUG: Placebo

Sponsor

FUJIFILM Toyama Chemical Co., Ltd.